Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs — an exploratory study

Bellamy, 1984, The causes of death in conventional land warfare: implications for combat casualty care research, Milit. Med., 149, 55, 10.1093/milmed/149.2.55 Bellamy, 1996, Suspended animation for delayed resuscitation, Crit. Care Med., 24/S, S24, 10.1097/00003246-199602000-00046 Safar, 1988, Resuscitation from clinical death: patho-physiologic limits and therapeutic potentials, Crit. Care Med., 16, 923, 10.1097/00003246-198810000-00003 Bigelow, 1950, Hypothermia, its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperature, Ann. Surg., 132, 849, 10.1097/00000658-195011000-00001 Tisherman, 1990, Therapeutic deep hypothermic circulatory arrest in dogs: a resuscitation modality for hemorrhagic shock with ‘irreparable’ injury, J. Trauma, 30, 836, 10.1097/00005373-199007000-00014 Tisherman, 1991, Profound hypothermia (<10°C) compared with deep hypothermia (15°C) improves neurologic outcome in dogs after 2 h circulatory arrest induced to enable resuscitative surgery, J. Trauma, 31, 1051, 10.1097/00005373-199131080-00002 Capone, 1996, Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 min in dogs, J. Trauma, 40, 388, 10.1097/00005373-199603000-00011 Connolly, 1965, Bloodless surgery by means of profound hypothermia and circulatory arrest: effect on brain and heart, Ann. Surg., 162, 724, 10.1097/00000658-196510000-00014 Safar, 1997, Resuscitation of the ischemic brain, 557 Safar, 1990, Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrest, Am. J. Emerg. Med., 8, 55, 10.1016/0735-6757(90)90298-E Woods, 1999, Hypothermic aortic arch flush for preservation during exsanguination cardiac arrest of 15 minutes in dogs, J. Trauma, 47, 1028, 10.1097/00005373-199912000-00007 Prueckner, 1999, Mild hypothermic aortic arch flush improves neurologic outcome from exsanguination cardiac arrest in dogs, Crit. Care Med., 27, A105, 10.1097/00003246-199901001-00267 Behringer, 1999, Outcome model in dogs of exsanguination cardiac arrest (CA) of 20 min with hypothermic aortic arch flush for cerebral preservation, Acad. Emerg. Med., 6, 251 Behringer, 1999, Complete cerebral recovery after 30-min cardiac arrest (CA) in dogs by preservative cold aortic flush, Circulation, 100/18, 1649 Tisherman, 1991, Feasibility of emergency cardiopulmonary bypass for resuscitation from CPR-resistant cardiac arrest — a preliminary report, Ann. Emerg. Med., 20, 491 Taylor, 1995, A new solution for life without blood: asanguinous low flow perfusion of a whole body perfusate during 3 h of cardiac arrest and profound hypothermia, Circulation, 91, 431, 10.1161/01.CIR.91.2.431 Tisherman, 1989, Exsanguination cardiac arrest in dogs: pathophysiology of dying, Ann. Emerg. Med., 18, 460, 10.1016/S0196-0644(89)80726-7 Tisherman, 1989, Exsanguination versus ventricular fibrillation cardiac arrest in dogs: comparison of neurologic outcome — preliminary data, Ann. Emerg. Med., 18, 460, 10.1016/S0196-0644(89)80727-9 Woods, 1999, Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs, Crit. Care Med., 27, A106, 10.1097/00003246-199901001-00271 Miller, 1992, Therapeutic potential for adenosine receptor activation in ischemic brain injury, J. Neurotrauma, 9, S563 Von Lubitz, 1994, Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia, Eur. J. Pharmacol., 256, 161, 10.1016/0014-2999(94)90241-0 Forman, 1993, Adenosine attenuates reperfusion injury following regional myocardial ischaemia, Cardiovasc. Res., 27, 9, 10.1093/cvr/27.1.9 Maggirwar, 1994, Adenosine acts as an endogenous activator of the cellular antioxidant defence system, Biochem. Biophys. Res. Commun., 201, 508, 10.1006/bbrc.1994.1731 Vinten-Johansen, 1995, Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy, Ann. Thorac. Surg., 60, 852, 10.1016/0003-4975(95)00571-2 Hudspeth, 1994, Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts, Ann. Thorac. Surg., 58, 1637, 10.1016/0003-4975(94)91650-0 Pitarys, 1991, Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period, Circulation, 83, 237, 10.1161/01.CIR.83.1.237 Grisham, 1989, Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation, Am. J. Physiol., 257, H1334 Kaminski, 1990, Actions of adenosine on nitro blue tetrazolium deposition and surface pH during intestinal reperfusion injury, Circ. Res., 66, 1713, 10.1161/01.RES.66.6.1713 Walus, 1981, Effects of adenosine and its derivatives on the canine intestinal vasculature, Gastroenterology, 82, 327, 10.1016/S0016-5085(81)80065-0 Marts, 1993, Protective effect of 2-chloro-adenosine on lung ischemia reperfusion injury, J. Surg. Res., 54, 523, 10.1006/jsre.1993.1081 Bell, 1998, Interstitial adenosine, inosine and hypoxanthine are increased after experimental traumatic brain injury in the rat, J. Neurotrauma, 15, 163, 10.1089/neu.1998.15.163 Bell, 1998, Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat, J. Neurotrauma, 15, 163, 10.1089/neu.1998.15.163 Pardridge, 1994, Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs, J. Pharmacol. Exper. Ther., 268, 14 Mahaffey, 1997, Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial, Circulation, 96, 206 Daly, 1995, Adenosine receptors: selective agonists and antagonists, 157 Sterz, 1992, Multifocal cerebral blood flow by Xe-CT and global cerebral metabolism after prolonged cardiac arrest in dogs: reperfusion with open-chest CPR or cardiopulmonary bypass, Resuscitation, 24, 27, 10.1016/0300-9572(92)90171-8 Nemoto, 1977, Global brain ischemia: a reproducible monkey model, Stroke, 8/5, 558, 10.1161/01.STR.8.5.558 Safar, 1982, Long-term animal models for the study of global brain ischemia, 147 Vaagenes, 1984, Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs, Crit. Care Med., 12, 846, 10.1097/00003246-198410000-00002 Leonov, 1990, Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs, J. Cereb. Blood Flow Metab., 10, 57, 10.1038/jcbfm.1990.8 Safar, 1996, Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion, Stroke, 27, 105, 10.1161/01.STR.27.1.105 Radovsky, 1995, Regional prevalence and distribution of ischemic neurons in dog brains 96 h after cardiac arrest of 0–20 min, Stroke, 26, 2127, 10.1161/01.STR.26.11.2127 Von Lubitz, 1997, Adenosine and acute treatment of cerebral ischemia and stroke — put out more flags, 449 Rudolphi, 1992, Adenosine and brain ischemia, Cereb. Brain Metab. Rev., 4, 346 Evans, 1987, An adenosine analogue, 2-chloro-adenosine, protects against long term development of ischaemic cell loss in the rat hippocampus, Neurosci. Lett., 83, 287, 10.1016/0304-3940(87)90101-7 Arvin, 1989, 2-Chloro-adenosine attenuated kainic acid-induced toxicity within the rat straitum: relationship to release of glutamate and Ca2+influx, Br. J. Pharmcol., 98, 225, 10.1111/j.1476-5381.1989.tb16886.x Jiang, 1997, Adenosine kinase inhibition protects brain against transient focal ischemia in rats, Eur. J. Pharmacol., 320, 131, 10.1016/S0014-2999(96)00905-3 Miller, 1996, Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats, Neurosci. Lett., 220, 73, 10.1016/S0304-3940(96)13234-1 Heron, 1994, Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia, Brain Res., 641, 217, 10.1016/0006-8993(94)90149-X O’Regan, 1992, The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex, Neurosci. Lett., 138, 169, 10.1016/0304-3940(92)90498-V Brodie, 1987, Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action, Brain Res., 415, 323, 10.1016/0006-8993(87)90214-9 Robertson, 1999, Assessment of 2-chloro-adenosine treatment after experimental traumatic brain injury in the rat using arterial spin-labeled MRI, Proc. Int. Soc. Magn. Reson. Med., 7, 896 Cronstein, 1994, Adenosine, an endogenous anti-inflammatory agent, J. Appl. Physiol., 76, 5, 10.1152/jappl.1994.76.1.5 Born, 1963, The aggregation of blood platelets, J. Physiol. (Lond.), 168, 178, 10.1113/jphysiol.1963.sp007185 Hossmann, 1980, Effect of intravascular platelet aggregation on blood recirculation following prolonged ischemia of the cat brain, J. Neurol., 222, 159, 10.1007/BF00313114 Von Lubitz, 1997, Adenosine A3 receptor and brain: a culprit, a hero, or merely yet another receptor?, Ann. N.Y. Acad. Sci., 825, 49, 10.1111/j.1749-6632.1997.tb48413.x Von Lubitz, 1994, Adenosine A3 receptor stimulation and cerebral ischemia, Eur. J. Pharmacol., 263, 59, 10.1016/0014-2999(94)90523-1 Behringer, 1999, Thiopental (TH) by aortic flush (AAF) for cerebral preservation in a 20 min exsanguination cardiac arrest (CA) exploratory dog study, Anesthesiology, 91, A251 Behringer, 1999, Fructose 1,6-biphosphate (FBP) by aortic arch flush (AAF) for cerebral preservation during 20 min exsanguination cardiac arrest (CA) in dogs: exploratory experiments, Acad. Emerg. Med., 6, 253 Behringer, 1999, Combination treatment of phenytoin and thiopental by aortic arch flush for cerebral preservation during 20 min exsanguination cardiac arrest (ExCA) in dogs: exploratory experiments, Crit. Care Med., 27, A29, 10.1097/00003246-199912001-00027 Behringer, 1999, Exploration of pharmacologic aortic arch flush strategies for rapid induction of suspended animation (SA) (cerebral preservation) during exsanguination cardiac arrest (ExCA) of 20 min in dogs, Crit. Care Med., 27, A65, 10.1097/00003246-199912001-00151